Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2020 Oct 19;11:446. doi: 10.1186/s13287-020-01913-2

Correction to: MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1

Mengge Wang 1,2,#, Hongtao Wang 1,2,#, Yuqi Wen 1,2, Xiaoyuan Chen 1,2, Xin Liu 1,2, Jie Gao 1,2, Pei Su 1,2, Yuanfu Xu 1,2, Wen Zhou 3, Lihong Shi 1,2,, Jiaxi Zhou 1,2,
PMCID: PMC7574475  PMID: 33076973

Correction to: Stem Cell Res Ther 9, 340 (2018)

https://doi.org/10.1186/s13287-018-1074-z

Following publication of the original article [1], the authors identified an editing error in Additional file 1: Fig. S1. They put the same picture in NANOG (MEIS2+/− 1#) and SOX2 (MEIS2+/− 2#) by mistake when they assembled the Fig. S1B. The heterozygous 1# and 2#, and homozygous 1# and 2# have been renamed as well.

The correct figure is given below.

Fig. 1.

Fig. 1

Targeted deletion of MEIS2 in human hESCs. (A) Surveyor assay of sgMESI2-E3G3-mediated cleavage at MEIS2 loci in H1 hESCs. (B) Immunofluorescence analysis of OCT4, SOX2, and NANOG in undifferentiated WT, MEIS2+/−, and MEIS2−/− hESCs. Scale bar, 80 μm.

Footnotes

Mengge Wang and Hongtao Wang contributed equally to this work.

Contributor Information

Lihong Shi, Email: shilhxys@ihcams.ac.cn.

Jiaxi Zhou, Email: zhoujx@ihcams.ac.cn.

Reference


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES